2024 |
Arcturus Therapeutics Holdings Inc
|
Independent Director |
- |
- |
2024 |
AnaptysBio Inc
|
Independent Director |
- |
- |
2023 |
AnaptysBio Inc
|
Independent Director |
318.4 K |
27.5 % |
2023 |
TransCode Therapeutics Inc
|
Independent Director |
75.1 K |
5.0 % |
2022 |
Arcturus Therapeutics Holdings Inc
|
Independent Director |
292.8 K |
-22.4 % |
2022 |
AnaptysBio Inc
|
Independent Director |
249.6 K |
-51.5 % |
2022 |
Immix Biopharma Inc
|
Independent Director |
89.3 K |
97.5 % |
2022 |
TransCode Therapeutics Inc
|
Independent Director |
71.5 K |
-49.2 % |
2021 |
AnaptysBio Inc
|
Independent Director |
514.2 K |
- |
2021 |
Arcturus Therapeutics Holdings Inc
|
Independent Director |
377.3 K |
56.6 % |
2021 |
TransCode Therapeutics Inc
|
Independent Director |
140.8 K |
- |
2021 |
Immix Biopharma Inc
|
Independent Director |
45.2 K |
- |
2020 |
Arcturus Therapeutics Holdings Inc
|
Independent Director |
240.9 K |
78.5 % |
2020 |
AnaptysBio Inc
|
Independent Director |
- |
- |
2020 |
Immix Biopharma Inc
|
Independent Director |
- |
- |
2020 |
TransCode Therapeutics Inc
|
Independent Director |
- |
- |
2019 |
Arcturus Therapeutics Holdings Inc
|
Independent Director |
135.0 K |
-23.6 % |
2018 |
Arcturus Therapeutics Holdings Inc
|
Independent Director |
176.8 K |
- |